Randhir Jesudoss, MD

Dr. Randhir Jesudoss is a board-certified gastroenterologist and hepatologist who serves as Director of Liver Diseases at Orlando Health West Medical Group in Florida. He practices within the Orlando Health system at Bayfront Hospital in St. Petersburg and Orlando Health Wiregrass Hospital in Wesley Chapel. His clinical practice focuses on comprehensive gastroenterology and advanced hepatology, including the management of chronic liver disease, cirrhosis, liver transplantation care, and gastrointestinal emergencies in both outpatient and inpatient settings.

Dr. Jesudoss has an extensive international medical background spanning more than two decades. He completed his medical education and early postgraduate training in India, including pediatrics and gastroenterology, before relocating to the United States for further training. He completed his internal medicine residency in the U.S., followed by a liver transplant fellowship at Temple University and advanced hepatology fellowship training at the University of Iowa. He subsequently joined the faculty at the University of Iowa, where he served for several years and also held the role of Chief of Liver Diseases at the Iowa City VA Medical Center.

Throughout his career, Dr. Jesudoss has been actively involved in teaching, clinical research, and academic medicine. His work includes contributions to liver disease management protocols, particularly in hepatitis C and transplant hepatology, including innovative approaches to expanding the use of hepatitis C-positive donor organs. He has published in peer-reviewed journals, contributed to medical textbooks, and remains engaged in physician education. He is a member of major professional organizations including the American College of Physicians, the American College of Gastroenterology, and the American Association for the Study of Liver Diseases.

• Madurai Medical College - MD

• MD
• American Board of Internal Medicine
• American Board of Gastroenterology

• GI Jeopardy National Championship (2021)

• American College of Physicians (ACP)
• American College of Gastroenterology (ACG)
• American Association for the Study of Liver Diseases (AASLD)

Randhir Jesudoss, MD

Professional Background & Academic Teaching
Experienced physician specializing in gastroenterology and hepatology.
Former faculty member at the University of Iowa, where he taught medical students, residents, and fellows.
Conducted Grand Rounds for physicians across multiple specialties.
Currently active in Florida, continuing academic involvement through lectures at gastroenterology meetings in the Tampa area.
Provides Grand Rounds for family medicine residents and physicians, with emphasis on liver and gastrointestinal diseases.

Clinical Research & Contributions
Conducted significant research on the treatment of chronic hepatitis C, particularly in:
Patients with a history of intravenous drug use.
Individuals co-infected with hepatitis B and HIV.
Pioneered innovative transplant protocols at the Veterans Hospital involving hepatitis C-positive organ donors.
Developed a treatment strategy for kidney transplant recipients receiving hepatitis C-positive organs, initiating antiviral therapy within three months post-transplant.
Helped establish a protocol that prevented post-transplant hepatitis C infection, preserving transplanted organs that were previously considered unusable.
Contributed to nationwide adoption of this approach, expanding the donor organ pool and reducing organ wastage.

Medical Education & Leadership
Trained fellowship teams in competitive academic settings, including GI Jeopardy.
Led teams to four national finals appearances, securing a National Championship in 2021.

Clinical Impact & Patient Outcomes
Demonstrates strong outcomes in managing liver disease, particularly in early-stage conditions.
Reports significant liver recovery in patients who discontinue alcohol use, even in cases of severe liver damage.
Highlights the life-changing impact of liver transplantation, transitioning patients from limited life expectancy (2–5 years) to full functional recovery.
Emphasizes restored quality of life post-transplant, including return to work and physical activities such as hiking and jogging.